Congratulations @Imspex_GAS on the granting of your patent for measurement of human breath using gas chromatography and ion mobility spectrometry. This is the foundation for the robust GC-IMS technology in BreathSpec® and FluidSpec® that has proven capability to screen for disease indications such as bacterial and viral respiratory tract infections, Group B Streptococcus infection, lung cancer and other chronic inflammatory respiratory conditions. This technology is a valuable tool for being able to identify disease conditions earlier and thereby start treatment earlier, and we are looking forward to expanding its reach.